bone marrow dose

bone mar·row dose

the cumulative dose to the blood-forming organ from therapeutic or nuclear fallout irradiation; the presumed leukemogenic dose.

bone mar·row dose

(bōn marō dōs)
Cumulative dose to the blood-forming organ from therapeutic or nuclear fallout irradiation; the presumed leukemogenic dose.
References in periodicals archive ?
It has been suggested that there is a 0.1-0.2% risk of developing AML within 10 years in patients receiving radiation therapy, and the incidence is higher in patients with a mean bone marrow dose of greater than 3.5 Gy.
The dosimetric estimations for absorbed doses after single or multiple Re-188-HEDP administration were (2.3 [+ or -] 0.9) cGy/37 MBq (1 mCi) bone marrow dose (BMD) and (71 [+ or -] 37) cGy total body marrow dose (TBMD) for the first group of patients (received single dose), while they are (1.6 [+ or -] 0.9) cGy/37 MBq (1 mCi) BMD and (83 [+ or -] 55) cGy TBMD for the second group (received multiple doses).